Correction: CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling
Mol Cancer. 2023 Oct 23;22(1):173.
doi: 10.1186/s12943-023-01881-0.
1 Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
2 Department of Urology, the Third Affiliated Hospital of Southern Medical University, Guangzhou, 510500, China.
3 Department of Urology, the Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510150, China.
4 Department of Radiotherapy, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, 510095, China.
5 Department of Radiotherapy Oncology, Yancheng City No.1 People's Hospital, Yancheng, 224005, China.
6 The Fourth Affiliated Hospital of Nantong University, Yancheng, 224005, China.
7 Department of Urology, Affiliated Tumor Hospital of Nantong University & Nantong Tumor Hospital, No. 30 Tongyang Bei Road, Tongzhou District, Nantong, 226361, China. wjc2469566287@163.com.
8 Department of Urology, Affiliated Wuxi No. 2 Hospital, Nanjing Medical University, Wuxi, 214002, China. fnh888@njmu.edu.cn.
9 Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China. lulululu@smu.edu.cn.
10 Department of Urology, the Third Affiliated Hospital of Southern Medical University, Guangzhou, 510500, China. lulululu@smu.edu.cn.